SCHEMBL7412975

SCHEMBL7412975

CC(=O)NC1C(=O)NC(=O)c2ccccc21

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.53
KMT2A Q03164 3/20 0.44
HTR7 P34969 1/20 0.43
HTR2B P41595 1/20 0.43
PSEN1 P49768 1/20 0.42
PSEN2 P49810 1/20 0.42
APH1B Q8WW43 1/20 0.42
NCSTN Q92542 1/20 0.42
APH1A Q96BI3 1/20 0.42
PSENEN Q9NZ42 1/20 0.42
KDM4E B2RXH2 3/20 0.41
HSD17B10 Q99714 2/20 0.41
MEN1 O00255 2/20 0.41
GAA P10253 2/20 0.41
HPGD P15428 1/20 0.41
LMNA P02545 1/20 0.41
TDP1 Q9NUW8 1/20 0.39
CASP3 P42574 1/20 0.39
MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL144326 0.79 KMT2A (0.65) KMT2AHTR7HTR2BMEN1GAA
SCHEMBL13135967 0.74 HSD17B10 (0.46) ALDH1A1KMT2AHTR2BKDM4EHSD17B10
SCHEMBL11792200 0.72 HDAC6 (0.45) ALDH1A1KMT2AKDM4EHSD17B10MEN1
SCHEMBL5551044 0.71 GSK3B (0.48) ALDH1A1HTR2BHSD17B10LMNACASP3
SCHEMBL11801695 0.69 HSD17B10 (0.47) ALDH1A1KMT2AHTR2BHSD17B10GAA
SCHEMBL5619249 0.69 PSEN1 (0.55) ALDH1A1KMT2APSEN1PSEN2APH1B
Phthalimide SCHEMBL8092178 0.69 GSK3B (0.62) ALDH1A1KMT2AKDM4EHSD17B10MEN1
SCHEMBL11844924 0.69 GSK3B (0.50) ALDH1A1HTR2BKDM4EHSD17B10HPGD
SCHEMBL10708943 0.68 HTR7 (0.57) KMT2AHTR7HTR2BMEN1GAA
Phthalimide SCHEMBL1132405 0.67 GSK3B (0.75) ALDH1A1KMT2AKDM4EHSD17B10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0252721-B1 4-NITROGEN SUBSTITUTED ISOQUINOLINOL COMPOUNDS HAVING CARDIOTONIC, PHOSPHODIESTERASE FRACTION III INHIBITING PROPERTIES AND/OR RENAL VASODILATING PROPERTIES ORTHO PHARMACEUTICAL CORPORATION (US) 1991-10-02 EP disclosed
US-4880817-A O-functionalized derivatives of substituted isoquinolin-3-ols having cardiotonic and/or phosphodiesterase fraction III inhibiting properties and/or renal vasodilating properties ORTHO PHARMACEUTICAL CORPORATION (US) 1989-11-14 US disclosed
US-4843077-A Isoquinoline derivatives having renal vasodilating properties and/or cardiotonic properties and/or phosphodiesterase inhibiting properties ORTHO PHARMACEUTICAL CORPORATION (US) 1989-06-27 US disclosed
EP-0252721-A1 4-Nitrogen substituted isoquinolinol compounds having cardiotonic, phosphodiesterase fraction III inhibiting properties and/or renal vasodilating properties ORTHO PHARMACEUTICAL CORPORATION (US) 1988-01-13 EP disclosed
US-4714705-A 4-nitrogen substituted isoquinolinol compounds having cardiotonic, phosphodiesterase fraction III inhibiting properties and/or renal vasodilating properties ORTHO PHARMACEUTICAL CORPORATION (US) 1987-12-22 US disclosed